Vimarsana
Biggest News Aggregation in the World

Compound Library News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compound Library. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compound Library Today - Breaking & Trending Today

Robust LC-MS workstream for toxicology analysis - Vimarsana News

Robust LC-MS workstream for toxicology analysis

Explore the Thermo Scientific™ Tox Explorer™ Collection

BioDuro-Sundia and X-Chem launch DEL technology services in China - Vimarsana News

BioDuro-Sundia and X-Chem launch DEL technology services in China

BioDuro-Sundia and X-Chem have collaborated to launch the DNA encoded compound library (DEL) technology services in China

BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in China for the Discovery of New - Vimarsana News

BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in China for the Discovery of New

SHANGHAI--(BUSINESS WIRE)--#DEL--BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound Library (DEL) technology services i...

BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs - Vimarsana News

BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs

SHANGHAI, Aug. 8, 2022 /PRNewswire/ --BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound Library (DEL) technology services in China to help more innovative pharmaceutical companies quickly discover small molecule drugs. X-Chem will leverage its powerful DEL technology platform and large collection of novel, diverse lead- and drug-like small molecule compounds to help customers significantly accelera...

Related Topics:
Xiang LiSteffen HelmlingContract ResearchAdvent InternationalManufacturing OrganizationCompound LibraryDrug Discovery PresidentAug 8022 Prnewswire Bioduro SundiaN Industry Leading Drug DiscoveryEvelopment And Commercial Service Crdmo Backed By Advent InternationalNdx ChemA Del Technology Pioneer In Small Molecule Drug DiscoveryOintly Announced The Launch Of Dna Encoded Compound Library Del Technology Services In China To Help More Innovative Pharmaceutical Companies Quickly Discover Small Molecule Drugsx Chem Will Leverage Its Powerful Platform And Large Collection NovelIverse Lead And Drug Like Small Molecule Compounds To Help Customers Significantly Accelerate The Discovery Of Hits Expand Their Target Range Combined With Bioduro Sundia 39s One Stop PlatformUstomers Can Access World Class Discovery Technologies And SupportOvering Hit Identification And OptimizationValuation Of Lead And Candidate CompoundsNd Quickly Advance To Preclinical Development Asa Pioneer In Del TechnologyX Chem 39s Libraries Contain Over 250 Billion Small Moleculesx Has Licensed More Than 100 Research Projects To Companies In The UsUrope And JapanOmprising Over Three Hundred Independent Chemical Series And More Than One Thousand Validated Hit Compounds Bioduro Sundia Will Utilize Its Powerful Protein Screening Platform To Assist Customers Complete The QualificationNsuring That Its PurityOncentration And Degree Of Aggregation Meet The Requirements For Compound Library Screening To Ensure Best Chances Hit Identification Quot We Are Very Pleased Collaborate With Bioduro Sundia In China Explore More New ChallengingAluable Therapeutic Targets
Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery - Vimarsana News

Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com